BioHealth News Archive
5 healthcare startup pitches that got it wrong (and why) – MedCity NewsMedCity News
Every startup is built on a number of assumptions and undoubtedly some of them will be incorrect. At Dreamit, I’m always stressing the importance…
Read More
Madison health IT startup wins national award | Technology | host.madison.com
Madison healthcare IT startup Redox won a prestigious award at a national healthcare technology conference this week. Redox, which helps app developers get access…
Read More
Immunomic Therapeutics licenses Hopkins-developed vaccine technology for $300M – Baltimore Sun
Immunomic Therapeutics, a biotechnology company developing a new type of vaccine based on Johns Hopkins research, has reached a $300 million deal licensing its…
Read More
Novavax Announces Positive Top-Line Data from Phase 2 Clinical Trial of RSV F Vaccine
Gaithersburg-based Novavax, Inc., (Nasdaq: NVAX) a clinical-stage vaccine company focused on the discovery, development and commercialization of recombinant nanoparticle vaccines and adjuvants, announced positive top-line…
Read More
Blackstone to buy BioMed Realty in $8 billion deal | Reuters
Blackstone Group LP agreed to buy BioMed Realty Trust Inc, a supplier of office space to healthcare companies, in a deal valued at $8…
Read More
10 projects from Hopkins’ MedHacks that might improve the healthcare system – Technical.ly Baltimore
College kids always close out the party, and Baltimore Innovation Week was no different. Students and other members of the Johns Hopkins community worked…
Read More
PathSensors receives SBIR grant from USDA
The UMD BioPark-based PathSensors, Inc. has been awarded a Small Business Innovation Research grant from the USDA’s National Institute of Food and Agriculture. The…
Read More
Novavax Announces Grant of Up to $89 Million to Support Development of RSV F Vaccine to Protect Infants Via Maternal Immunization
Novavax, Inc., (Nasdaq:NVAX) a clinical-stage vaccine company focused on the discovery, development and commercialization of recombinant nanoparticle vaccines and adjuvants, today announced it has…
Read More
Intrexon Establishes First Collaboration with Dedicated Fund – Oct 1, 2015
Intrexon Corporation (NYSE: XON), a leader in synthetic biology, announced today that it has entered into its first Exclusive Channel Collaboration (ECC) with a…
Read More
Circulomics Wins $1.5M Phase II SBIR Grant for DNA/RNA Extraction Tech – GenomeWeb
Circulomics today announced a $1.5 million Phase II Small Business Innovation Research (SBIR) grant from the National Institute of General Medical Sciences to create…
Read More
Telemedicine Is Vital to Reforming Health Care Delivery
Health care remains one of the few services that require people to have a face-to-face interaction to obtain access. But more and more consumers…
Read More
Wake Forest Baptist creates $15 million program to develop life science technologies – Winston-Salem Journal: Local News
Wake Forest Baptist Medical Center has created a $15 million program to develop the ideas, discoveries and inventions of its faculty and staff members…
Read More
How Baltimore can become a national leader in commercialized technologies – Technical.ly Baltimore
Disruption is coming for the big, regulated industries that were once investment no-nos: education, energy, healthcare and the sciences. And that’s good news for Baltimore.…
Read More
Boston Scientific Launches Online Competition For New Digital Health Technologies – MarketWatch
Boston Scientific BSX, +1.51% this week announced the start of the Boston Scientific Connected Patient Challenge, an open innovation contest designed to encourage advancements…
Read More
FDA Opens Door For 23andMe To Market Some Direct-To-Consumer Genome Tests – Fast Company
An FDA decision summary released today allows DNA-testing company 23andMe to market a genome test that screens for Bloom syndrome, a rare disorder that…
Read More